Royal Bank of Canada’s Boston Scientific BSX Stock Holding History

Royal Bank of Canada’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-12,000	Closed	-$431K	–	7428
2020 Q4	$431K	Hold	12,000	–	–	﹤0.01%	4261
2020 Q3	$459K	Hold	12,000	–	–	﹤0.01%	3930
2020 Q2	$421K	Hold	12,000	–	–	﹤0.01%	3924
2020 Q1	$392K	Hold	12,000	–	–	﹤0.01%	3826
2019 Q4	$543K	Sell	12,000 -30,000	-71%	-$1.26M	﹤0.01%	3922
2019 Q3	$1.71M	Sell	42,000 -5,500	-12%	-$233K	﹤0.01%	2889
2019 Q2	$2.04M	Buy	+47,500	New	+$1.83M	﹤0.01%	2752
2019 Q1	–	Sell	-900	Closed	-$32K	–	6808
2018 Q4	$32K	Buy	+900	New	+$32.6K	﹤0.01%	5337

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada's BSX Position: Q1 2026 in Review

Royal Bank of Canada increased its Boston Scientific (BSX) stake by 13% in Q1 2026, buying an estimated $57.7M and bringing the position to 6,273,263 shares worth $394M. The position accounts for 0.07% of the portfolio, ranked #257.

Royal Bank of Canada first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $753M in Q3 2025. 1,672 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Royal Bank of Canada held 6,273,263 shares of Boston Scientific worth $394M as of Q1 2026.
Royal Bank of Canada bought 721,691 Boston Scientific shares in Q1 2026, an estimated $57.7M.
Boston Scientific made up 0.07% of Royal Bank of Canada's portfolio in Q1 2026, its #257 holding.
Royal Bank of Canada first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
Royal Bank of Canada's Boston Scientific position peaked at $753M in Q3 2025.
1,672 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.